Mangoceuticals, Interest Expense vs Ebitda Analysis
MGRX Stock | 2.48 0.14 5.34% |
Mangoceuticals, Common financial indicator trend analysis is infinitely more than just investigating Mangoceuticals, Common recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mangoceuticals, Common is a good investment. Please check the relationship between Mangoceuticals, Common Interest Expense and its Ebitda accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangoceuticals, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Interest Expense vs Ebitda
Interest Expense vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mangoceuticals, Common Interest Expense account and Ebitda. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Mangoceuticals, Common's Interest Expense and Ebitda is -0.02. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Ebitda in the same time period over historical financial statements of Mangoceuticals, Common Stock, assuming nothing else is changed. The correlation between historical values of Mangoceuticals, Common's Interest Expense and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of Mangoceuticals, Common Stock are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Interest Expense i.e., Mangoceuticals, Common's Interest Expense and Ebitda go up and down completely randomly.
Correlation Coefficient | -0.02 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Ebitda
Most indicators from Mangoceuticals, Common's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mangoceuticals, Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangoceuticals, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Selling General Administrative is likely to rise to about 6.8 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 4.1 M in 2024.
2010 | 2023 | 2024 (projected) | Gross Profit | 4.9K | 431.5K | 240.0K | Total Revenue | 8.9K | 731.5K | 407.2K |
Mangoceuticals, Common fundamental ratios Correlations
Click cells to compare fundamentals
Mangoceuticals, Common Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.